Author:
Konjevoda Suzana,Čanović Samir,Didović Pavičić Ana
Abstract
The outbreak of new Cov-2 epidemic was detected in December 2019 in the city of Wuhan, China, caused by Severe Acute Respiratory Syndrome Coronavirus −2 and started its rapid spread througth the world. The World Health Organisation (WHO) declared a public health emergency of international concern (PHEIC) on the 30th of January 2020. -2 infection can present with spectrum of clinical manifestations, primary of upper respiratory tract and in some cases, especially in immunocompromised patients can cause changes in lower respiratory tract such as pneumonia and bronchitis. Conjunctivitis is not a common manifestation of SARS-Cov-2 infection. It should however be kept in mind that patients with ocular manifestations and symptoms can represent the COVID-19 cases. CoVs can produce several ocular manifestations from conjunctivitis, uveitis – anterior and posterior, retinitis and optic neuritis.
Reference23 articles.
1. Organisation WH. Coronavirus disease 2019 (COVID19) situation report 32.https://who.int/docs/default-source/coronaviruse/situation-reports/20200221-sitrep-32-covid-19
2. Organisation WH. Statement on the second meeting of the international health regulations (2005) emergency commettee regarding the outbreak of novel coronavirus (2019-n-Cov). https://www.who.int/news-room/detail/30-01-2020
3. Corman VM, Muth D, niemeyer D, Drosten C. Hosts and sources of endemic human coronaviruse. Adv Virus Res. 2018;100:163-188
4. Vassilara F, Spyridaki A, Pothitos G, Deliveliotou A, Papadopulos A. A rare case of human coronavirus 229E associated with acute respitarory distress syndrome in healthy adult. Case Rep Infect Dis. 2018;2018:6796839
5. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020.